SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Ingredient guide · Ingredient reference

    MSM for knee pain: what a small pilot did and did not show

    Pain and function improved in a twelve-week trial, while stiffness and the combined symptom score did not.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026

    The study and its comparison

    Fifty adults aged 40–76 with knee osteoarthritis entered a masked trial of MSM 3 grams twice daily or placebo for twelve weeks. Pain, physical function and general health were measured. [1]

    MSM improved the reported pain and physical-function measures relative to placebo. Stiffness and aggregate WOMAC symptoms did not show notable changes. [1]

    What the finding establishes

    The study was a small pilot and did not establish long-term benefit, cartilage preservation or long-term safety. Funding and conflicts were not established from the abstract. Results for MSM alone cannot be assigned automatically to a lower-dose multi-ingredient joint product. [1]

    A hypothetical distinction

    Imagine a combined score remains unchanged despite one improved component. Report the component rather than calling every symptom improved.

    Interpretation checklist — MSM for knee pain
    DetailInterpretation
    Measured outcomeKeep the endpoint specific
    Study preparationNot every retail product
    Remaining uncertaintyNot resolved by a mechanism
    MSM for knee pain: what a small pilot did and did not show — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial.
      Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.